Skip to content

Safety evaluation of test products within 24 hours on skin.

Dermatological safety evaluation of test products by Primary Irritation Patch Test within 24 hours of apply on healthy human all skin types.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039071
Enrollment
24
Registered
2022-01-03
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Vasu Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Voluntary men and women ration of 1:1 between 18 and 65 years. Having healthy skin on test area as assessed by dermatological examination. For whom the investigator considers that the compliance will be correct. Subjects with normal, dry, oily and combination skin Subjects cooperating informed of the need and duration of the examination and ready to comply with protocol procedures. Having a signed consent form. Subjectsââ?¬• willingness to avoid intense UV exposure on test site (sun or artificial UV), during the study. Willingness to avoid excessive water contact (for example swimming) or activity which causes excessive sweating (that is exercise, sauna ââ?¬Â¦.), during the study. Having valid proof of identity and age. Volunteers evaluated with Fitzpatrick skin type 3 to 5 as per the Fitzpatrick scale (Appendix IV).

Exclusion criteria

Exclusion criteria: Pregnant/nursing mothers. Scars, excessive terminal hair, or tattoo on the studied area. Dermatological infection/pathology on level of studied area. Hypersensitivity, allergy antecedent (to any cosmetic product, raw material) Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures. ââ??? Chronic illness which may influence the outcome of the study. Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month). Subject in an exclusion period or participating in another food, cosmetic, or therapeutic trial. Volunteers evaluated with Fitzpatrick skin type 1,2 and 6 as per the Fitzpatrick scale (Appendix IV).

Design outcomes

Primary

MeasureTime frame
Number of subjects that showed No significant irritation. Score of less than or equal to 2 on the Draize scale. Timepoint: Day0,Day1,Day2, Day3, Day4, Day5

Secondary

MeasureTime frame
N/ATimepoint: N/A

Countries

India

Contacts

Public ContactMeena Dalal

Trial Guna Pvt Ltd

dhavala72@gmail.com9590959080

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026